ACR guidelines include TNF and IL inhibitors as second-line therapies.
Findings from large-scale VA research show independent role of MVD.
Largest study yet clarifies presentation, diagnostics and treatment.
Preoperative opioid use before elective surgery brings elevated risk and costs.
New research encourages early recognition and steroid-sparing treatment.
Large-scale EHR analysis reveals key differences in SLE outcomes and treatment responses.
New findings reinforce the need for individualized prescribing, alternative regimens.
1 / 5
Study shows frequent opioid reliance despite lack of evidence of benefit and increased risk.
Little understood, the role of microbial sRNAs may be a pathway to personalizing treatment.
Leveraging vast patient data sets is both confirming and revealing new genome-phenome associations.